Patent · US Expired

4-Pyrimidinyl-n-acyl-l phenylalanines

US6380387B1 · kind B1 · utility

30Cited by
0References
61Claims
0Family size

Assignee

Inventors

Key dates

Filing dateNov 21, 2000
Grant dateApr 30, 2002
Priority date—
Expiry dateNov 21, 2020

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K38/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Compounds of Formula I are disclosed, having activity as inhibitors of binding between VCAM-1 and cells expressing VLA-4, and accordingly useful for treating diseases whose symptoms and or damage are related to the binding of VCAM-1 to cells expressing VLA-4.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.